There are 2789 resources available
Melanoma and other skin tumours
Presenter: Omid Hamid
Session: Expert selection 2
Resources:
Slides
Webcast
Drug development: How can academia and industry work together
Presenter: Jean-Charles Soria
Session: Keynote lecture: Drug development: How can academia and industry work together
Resources:
Slides
Webcast
Introduction by the Chair
Presenter: Jordi Rodon
Session: Keynote lecture: Drug development: How can academia and industry work together
Resources:
Slides
Webcast
LBA15 - Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer
Presenter: Cristina Saura Manich
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
1123O - Evaluation of cell-free DNA approaches for multi-cancer early detection
Presenter: Minetta Liu
Session: Proffered Paper session - Translational research
Resources:
Abstract
Slides
Webcast
653O - Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564
Presenter: Toni Choueiri
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
340O - Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients
Presenter: Emre Kocakavuk
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
342O - Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
Presenter: Bart Neyns
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
LBA56 - Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
Presenter: Thomas Seufferlein
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA16 - KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC
Presenter: Hope Rugo
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast